Eli Lilly and Company (LLY) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Eli Lilly And Company.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.056 Thank you for holding. We look forward to talking with you soon. 00:00:04.056 -- 00:00:07.938 Please hold the line and we'll be right back with you. 00:00:24.180 -- 00:00:29.286 Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q3 2025 Earnings 00:00:29.286 -- 00:00:33.447 Conference Call. At this time, all participants are on a listen-only mode. 00:00:33.447 -- 00:00:36.811 Later, we will be conducting a question and answer session, and instructions will be 00:00:36.811 -- 00:00:41.096 given at that time. Should you request assistance during the call, please press star, 00:00:41.096 -- 00:00:44.279 then zero, and an operator will assist you offline. 00:00:44.279 -- 00:00:48.624 I would now like to turn the conference over to your host, Mike Zappar, Senior Vice President 00:00:48.624 -- 00:00:52.146 of Investor Relations. Please go ahead. 00:00:52.429 -- 00:00:57.895 Good morning. Thank you for joining us for Eli Lillian Company's Q3 2025 earnings call. 00:00:57.895 -- 00:01:01.399 I'm Mike Sabar, Senior Vice President of Investor Relations. 00:01:01.399 -- 00:01:06.306 Joining me on today's call are Dave Ricks, Lilly's Chair and CEO, Lucas Montarse, Chief 00:01:06.306 -- 00:01:11.372 Financial Officer, Dr. Dan Skowronski, Chief Scientific Officer and President of Lilly 00:01:11.372 -- 00:01:16.839 Immunology, Anne White, President of Lilly Neuroscience, Ilya Yufa, President of Lilly 00:01:16.839 -- 00:01:22.286 USA and Global Customer Capabilities, Jake Van Narden, President of Lilly Oncology, 00:01:22.286 -- 00:01:26.712 Patrick Johnson, President of Lilly International, and Ken Custer, President of Lilly 00:01:26.712 -- 00:01:29.063 Cardiometabolic Health. 00:01:29.063 -- 00:01:33.527 We're also joined by ...